Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic ergometrine versus oxytocin in the third stage of labor
PACTR201105000292708Completed
- Sponsor
- Dr. Ezeama C. O. Clinic
- Start
- Jun 2011
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of ergonovine maleate and oxytocin in postpartum hemorrhage (PPH) (2 arms), sponsored by Dr. Ezeama C. O. Clinic. Primary endpoints: Postpartum blood loss greater than 500 mL and Short-term adverse effects within 30 minutes. Started Jun 2011; status: completed.
02
Drugs
ergonovine maleateoxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on PACTR201105000292708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201105000292708.